|
|
|
 |
| Location: Home -
Products - Reference Compounds&Impurities - Anti-Cancer(Oncology) Agents
|
Mocetinostat(MGCD0103)
| Catalogue No. : |
C13902 |
| Product Name: |
Mocetinostat(MGCD0103) |
| Synonym: |
MG 0103;MGCD 0103;MGCD0103;MGCD-0103 |
| Chemical Name: |
N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide |
| CAS No. : |
726169-73-9 |
| Structure : |
|
| Molecular Formula: |
C23H20N6O |
| Molecular Weight: |
396.44 |
| Purity: |
>98% |
| Usage: |
Mocetinostat is a multi-targeted histone deacetylase inhibitor used in cancer therapy. Mocetinostat is undergoing clinical trials for the treatment of various cancers including follicular lymphoma, Hodgkin’s lymphoma and acute myelogenous leukemia. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
